The Dynamic Use of EGFR Mutation Analysis in Cell-Free DNA as a Follow-Up Biomarker during Different Treatment Lines in Non-Small-Cell Lung Cancer Patients

Por Mónica Macías, Estibaliz Alegre, Gorka Alkorta-Aranburu, Ana Patiño-García, Beatriz Mateos, Maria P. Andueza, Alfonso Gúrpide, Jose M. Lopez-Picazo, Ignacio Gil-Bazo, Jose L. Perez-Gracia, Álvaro González
Publicado em 2019-01-01